SaNOtize’s NONS Phase 2 study proves efficacy in COVID-19 treatment

By Nikita Chaurasia  Date: 2021-03-16

SaNOtize’s NONS Phase 2 study proves efficacy in COVID-19 treatment

Vancouver-headquartered biotechnology organization, SaNOtize Research & Development Corp has announced the results of its Phase 2 trials of Nitric Oxide Nasal Spray, abbreviated as NONS, for the treatment of patients diagnosed with COVID-19.

For those uninitiated, NONS treatment is based on NO (nitric oxide), a natural nano molecule produced in the human body which exhibits anti-microbial properties and characteristics proven to have a direct effect on the Coronavirus. Moreover, the treatment is designed to kill the virus in the upper airways, barricading its incubation and entry into the lungs.

According to reliable sources, the phase 2 clinical trials indicated that SaNOtize’s NONS is an effective and safe antiviral treatment that prevents the transmission of the coronavirus, shortens its course, and significantly reduces the severity of symptoms in individuals already diagnosed.

SaNOtize has issued a press release stating that the Phase 2 clinical trials found that early treatment of COVID-19 patients with NONS substantially reduced the levels of SARS-CoV-2 coronavirus, including in individuals experiencing high viral loads. Notably, NONS is the only treatment that has proven to reduce viral loads in humans.

If sources are to be believed, the preliminary data comes from a double-blind, placebo-controlled, randomized clinical trial round conducted on 79 confirmed cases of COVID-19. Furthermore, the trials recorded an average viral log of 1.362 in the first 24 hours, which is a decline of around 95%.

This was followed by a 99% drop of the viral load within 72 hours of the commencement of the test, sources confirmed.

Gilly Regev, Co-founder, and CEO of SaNOtize, was reported saying that the biotech company will now focus on efficiently administering the vaccine among the masses and will work towards bringing an end to the ongoing pandemic as well as preventing future outbreaks of relevant viruses.

SaNOtize is currently seeking Emergency Use Authorization from regulatory authorities in Canada and the United Kingdom.

Source credits –

 https://www.businesswire.com/news/home/20210315005197/en/UK-Clinical-Trial-Confirms-SaNOtize%E2%80%99s-Breakthrough-Treatment-for-COVID-19

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

CI NMF, Amp Energy India to jointly invest USD 200 Mn in renewables

CI NMF, Amp Energy India to jointly invest USD 200 Mn in renewables

By Nikita Chaurasia

Copenhagen Infrastructure Partners, one of the biggest renewable energy-centered fund managers worldwide, has signed an agreement with Amp Energy India Pvt Ltd. for joint equity investments of USD 200 million in renewables, using its Copenhagen Infra...

CDC updates guidelines, calls for vaccinated people to mask up

CDC updates guidelines, calls for vaccinated people to mask up

By Nikita Chaurasia

The Centers for Disease Control and Prevention issued new guidelines suggesting that people who are vaccinated against Covid-19 wear masks in public as well as indoor areas where the rate of the disease is high. The CDC also stated that teachers, sta...

iPhone’s hot streak could be hampered by global chip shortage crisis

iPhone’s hot streak could be hampered by global chip shortage crisis

By Nikita Chaurasia

Apple Inc. recently stated that the global chip shortage that has affected the sales of Macs and iPads, will now hit iPhone production and the expected revenue growth is likely to decelerate. This has resulted in lowering Apple’s shares. The c...

EV maker Rivian bags USD 2.5 Bn in a funding round led by Amazon, Ford

EV maker Rivian bags USD 2.5 Bn in a funding round led by Amazon, Ford

By Nikita Chaurasia

American electric vehicle maker Rivian Automotive LLC reportedly secured USD 2.5 billion in a funding round led by Amazon.com Inc, T. Rowe Price, D1 Capital Partners, and Ford Motor Co. In addition, the event also saw participation from Fidelity Man...

ICEA forms committee chaired by HP India MD to boost IT hardware sector

ICEA forms committee chaired by HP India MD to boost IT hardware sector

By Nikita Chaurasia

The India Cellular & Electronics Association (ICEA) recently announced the formation of a committee to promote manufacturing and exports of the IT hardware sector. The panel headed by Ketan Patel, HP India’s Managing Director, will set up a...